Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia - Université de Lorraine
Journal Articles Cancer Year : 2017

Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia

Annalisa Ruggeri
  • Function : Author
  • PersonId : 973514
Eolia Brissot
Remy Dulery
Mohamad Mohty
  • Function : Author
  • PersonId : 953688
Fichier principal
Vignette du fichier
S2152265019301090.pdf (187.72 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-01777827 , version 1 (25-10-2021)

Licence

Identifiers

Cite

Giorgia Battipaglia, Annalisa Ruggeri, Radwan Massoud, Jean El Cheikh, Matthieu Jestin, et al.. Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia. Cancer, 2017, 123 (15), pp.2867 - 2874. ⟨10.1002/cncr.30680⟩. ⟨hal-01777827⟩
103 View
113 Download

Altmetric

Share

More